FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma – Curetoday.com
FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell LymphomaCuretoday.comThe Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR-T cell therapy – for the treatment of adult patients who have relapsed or refractory diffus… Continue reading
